Neoplasms: all 9,610 studies
Page 93 of 97. Open to participants first (2,508), then studies with results posted, then the rest; newest registration first within each.
- Study of Motexafin Gadolinium and Docetaxel for Advanced CancerCompletedNCT00120939Phase 1
- Treatment for Anemic Subjects With Non-Myeloid Malignancies Receiving ChemotherapyCompletedNCT00120705Phase 2
- NORCCAP: Norwegian Colorectal Cancer Prevention TrialActive, not recruitingNCT00119912Not applicable
- A Study of AMG 114 Administered by Subcutaneous Injection for the Treatment of Anemia in Subjects With Non-Myeloid Malignancies Receiving Multicycle ChemotherapyTerminatedNCT00119600Phase 1/2
- 17-AAG and Irinotecan in Treating Patients With Locally Advanced or Metastatic Solid TumorsCompletedNCT00119236Phase 1
- Ispinesib In Combination With Capecitabine In Patients With Solid TumorsCompletedNCT00119171Phase 1
- A Study of Darbepoetin Alfa for the Treatment of Anemia in Subjects With Non-Myeloid Malignancy Receiving Multicycle ChemotherapyCompletedNCT00118638Phase 3
- Calcitriol in Preventing Prostate Cancer in Patients With Prostatic Intraepithelial NeoplasiaTerminatedNCT00118066Phase 2
- A Study of Darbepoetin Alfa for the Treatment of Anemia in Subjects With a Non-Myeloid MalignancyCompletedNCT00117624Phase 3
- A Pilot Trial of Oral Topotecan for the Treatment of Refractory Advanced Solid Neoplasms Expressing HIF-1aCompletedNCT00117013Phase 1
- Phase I Study of Cisplatin Plus OSI-7904L in Patients With Solid TumorsCompletedNCT00116896Phase 1
- Study of TPI 287 in Patients With Advanced MalignanciesCompletedNCT00113724Phase 1
- Subcutaneously Administered CAMPATH in CD52 Expressing Hematologic MalignanciesTerminatedNCT00113048Phase 1
- Alpha-Lipoic Acid in Preventing Peripheral Neuropathy in Patients Receiving Chemotherapy for CancerCompletedNCT00112996Phase 3
- Irinotecan and Selenium in Treating Patients With Advanced Solid TumorsCompletedNCT00112892Phase 1
- Alvocidib in Treating Patients With Locally Advanced or Metastatic Solid TumorsTerminatedNCT00112684Phase 1
- Topotecan in Treating Young Patients With Neoplastic Meningitis Due to Leukemia, Lymphoma, or Solid TumorsTerminatedNCT00112619Phase 1
- Study of Oral Ridaforolimus (AP23573, MK-8669) to Treat Patients With Refractory or Advanced Malignancies (MK-8669-016 AM4)(COMPLETED)CompletedNCT00112372Phase 1
- Magnetic Resonance Imaging Guided Gynecologic BrachytherapyCompletedNCT00112307Not applicable
- OVCA-NAC-P2: Study of Chemotherapy Followed by Cytoreductive Surgery for Ovarian, Tubal and Peritoneal Cancers: JCOG0206CompletedNCT00112086Phase 2
- Evaluating Treatment of Anemia in Subjects With Non-Myeloid MalignanciesReceiving Multicycle ChemotherapyCompletedNCT00111462Phase 2
- Treatment for Patients With Non-Myeloid Malignancies Receiving ChemotherapyCompletedNCT00111137Phase 3
- Treatment of Anemia in Subjects With Non-Myeloid Malignancy Receiving Multicycle ChemotherapyCompletedNCT00110955Phase 3
- Gene Therapy for Prostate Cancer That Returns After Radiation TherapyWithdrawnNCT00110526Phase 1
- Positron Emission Tomography Using Fluorine F 18 EF5 to Find Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Newly Diagnosed Brain TumorsTerminatedNCT00110032Phase 1
- Campath-1H + FK506 and Methylprednisolone for GVHDCompletedNCT00109993Phase 2
- Valproic Acid in Treating Young Patients With Recurrent or Refractory Solid Tumors or CNS TumorsCompletedNCT00107458Phase 1
- Neoadjuvant Colorectal Cancer With Unresectable Liver MetastasesTerminatedNCT00106054Phase 2
- Safety and Tolerability of hCBE-11 in Subjects With Advanced Solid TumorsTerminatedNCT00105170Phase 1
- Use of ACA 125 in Patients With Ovarian Cancer: Safety and Immune ResponseCompletedNCT00103545Phase 1/2
- SJG-136 in Treating Patients With Advanced Solid TumorsCompletedNCT00103220Phase 1
- A Research Study of CP-724,714 in Patients With HER2 Overexpressing Metastatic Breast CancerTerminatedNCT00102895Phase 2
- Study Evaluating AMG 386 in Adult Patients With Advanced Solid TumorsCompletedNCT00102830Phase 1
- Study of Safety and Efficacy of Glufosfamide in Combination With Gemcitabine in CancerCompletedNCT00102752Phase 1/2
- A Safety Study Utilizing Yondelis and Doxorubicin in Patients With a Type of Cancer Called Soft Tissue SarcomaCompletedNCT00102609Phase 1
- Vinflunine in Patients With Locally Advanced or Metastatic Transitional Cell Carcinoma of the UrotheliumCompletedNCT00101608Phase 2
- Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or LymphomasCompletedNCT00101270Phase 1
- Lenalidomide in Treating Young Patients With Recurrent, Progressive, or Refractory CNS TumorsCompletedNCT00100880Phase 1
- Study to Determine the Maximum Tolerated Dose of LErafAON in Patients With Advanced CancerCompletedNCT00100672Phase 1
- Comparison of Liposome Entrapped Paclitaxel Easy to Use (LEP-ETU) and Taxol® Pharmacokinetics in Patients With Advanced CancerCompletedNCT00100139Phase 1
- A Study to Assess the Efficacy of Intravenous Bondronat (Ibandronate) in Patients With Malignant and Painful Bone DiseaseTerminatedNCT00099203Phase 3
- Talotrexin in Treating Patients With Advanced or Recurrent Solid TumorsCompletedNCT00098514Phase 1
- CCI-779 and EKB-569 in Treating Patients With Advanced Solid TumorsCompletedNCT00098501Phase 1
- The CAT Study: Atamestane Plus Toremifene Versus Letrozole in Advanced Breast CancerTerminatedNCT00097344Phase 3
- Paclitaxel and ABI-007 in Treating Patients With Locally Advanced or Metastatic Solid TumorsCompletedNCT00095914Phase 1
- BMS-599626 in Patients With Advanced Solid MalignanciesCompletedNCT00095537Phase 1
- Study of NS-9 in Patients With Liver MetastasesCompletedNCT00094003Phase 1
- Study Evaluating AMG 706 in Subjects With Advanced Solid TumorsCompletedNCT00093873Phase 1
- Tanespimycin in Treating Young Patients With Recurrent or Refractory Leukemia or Solid TumorsCompletedNCT00093821Phase 1
- Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease ActivityActive, not recruitingNCT00092222Phase 2
- Two Dose Schedules of Panitumumab in Subjects With Advanced Solid TumorsCompletedNCT00091806Phase 1
- Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous TreatmentCompletedNCT00091182Phase 2
- Bortezomib in Treating Patients With Advanced Cancer and Liver DysfunctionCompletedNCT00091117Phase 1
- Chemotherapy for Patients With Advanced Solid Tumors or Non-Hodgkin's LymphomaStatus unknownNCT00090727Phase 1
- Acupuncture for Women's Health ConditionsCompletedNCT00090389Phase 1
- GVAX® Vaccine for Prostate Cancer vs Docetaxel & Prednisone in Patients With Metastatic Hormone-Refractory Prostate CancerTerminatedNCT00089856Phase 3
- AZD5438 in Patients With Advanced Solid MalignanciesCompletedNCT00088790Phase 1
- Study Evaluating MST-997 in Advanced Malignant Solid TumorsTerminatedNCT00088647Phase 1
- STA-5312 Administered on Alternate Weekdays Every Two Weeks to Patients With Hematologic Malignancies and Patients With Solid TumorsCompletedNCT00088101Phase 1
- EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung CancerTerminatedNCT00087191Not applicable
- Rebeccamycin Analog and Oxaliplatin in Treating Patients With Refractory Solid TumorsTerminatedNCT00086983Phase 1
- Ifosfamide With or Without O(6)-Benzylguanine in Treating Patients With Unresectable, Metastatic Solid TumorsTerminatedNCT00086970Phase 1
- Study of AP23573 in Patients With Relapsed or Refractory Hematologic Malignancies (8669-024)(COMPLETED)CompletedNCT00086125Phase 2
- Dose-Escalation Study Of SB-485232 Administered As Daily Subcutaneous Injections In Adults With Solid TumorsCompletedNCT00085878Phase 1
- A Study of ARRY-142886 in Patients With Advanced CancerCompletedNCT00085787Phase 1
- Alemtuzumab Plus Fludarabine and Melphalan With or Without Cyclosporine, Mycophenolate Mofetil, and Low-Dose Total-Body Irradiation Therapy Followed by Donor Peripheral Stem Cell Transplant in Treating Patients With Hematologic CancerWithdrawnNCT00085449Phase 1/2
- Bevacizumab in Treating Young Patients With Refractory Solid TumorsCompletedNCT00085111Phase 1
- Safingol and Cisplatin in Treating Patients With Locally Advanced or Metastatic Solid TumorsCompletedNCT00084812Phase 1
- Gefitinib and Docetaxel in Treating Patients With Advanced Solid TumorsCompletedNCT00084786Phase 1
- Docetaxel, Capecitabine, and Cisplatin in Treating Patients With Advanced Solid TumorsCompletedNCT00084734Phase 1
- Calcitriol and Gefitinib With or Without Dexamethasone in Treating Patients With Advanced Solid TumorsCompletedNCT00084708Phase 1
- Romidepsin in Treating Patients With Locally Advanced or Metastatic Neuroendocrine TumorsTerminatedNCT00084461Phase 2
- Study Evaluating CCI-779 and Letrozole in Post-menopausal Women With Breast CancerTerminatedNCT00083993Phase 3
- Urokinase-Plasminogen Activator (uPA) Inhibitor WX-UK1 in Combination With Capecitabine in Advanced MalignanciesCompletedNCT00083525Phase 1
- Bortezomib and Flavopiridol in Treating Patients With Recurrent or Refractory Indolent B-Cell NeoplasmsCompletedNCT00082784Phase 1
- Genetic Analysis in Identifying Late-Occurring Complications in Childhood Cancer SurvivorsCompletedNCT00082745
- Study of the Emotional Needs of Caregivers of Stem Cell Transplantation PatientsCompletedNCT00082654Not applicable
- Aroplatin and Gemcitabine in Patients With Advanced Pancreatic Cancer Resistant to Standard TherapiesStatus unknownNCT00081549Phase 1/2
- Aroplatin and Capecitabine in Patients With Advanced Colorectal Cancer Resistant to Standard TherapiesStatus unknownNCT00081536Phase 1/2
- Alvocidib, Oxaliplatin, Fluorouracil, and Leucovorin Calcium in Treating Patients With Advanced Solid TumorsCompletedNCT00080990Phase 1
- T-Cell-Depleted Allogeneic Stem Cell Transplantation After Immunoablative Induction Chemotherapy and Reduced-Intensity Transplantation Conditioning in Treating Patients With Hematologic MalignanciesCompletedNCT00080925Phase 1
- Liposome Entrapped Paclitaxel Easy to Use (LEP-ETU) in Patients With Advanced CancerCompletedNCT00080418Phase 1
- Study of Motexafin Gadolinium and Docetaxel for Advanced Solid TumorsCompletedNCT00080041Phase 1
- GTI-2040 and Gemcitabine in Treating Patients With Metastatic or Unresectable Solid TumorsCompletedNCT00078962Phase 1
- Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell TransplantCompletedNCT00078858Phase 1/2
- Genasense® (Oblimersen Sodium), Fludarabine, and Rituximab in Subjects With Chronic Lymphocytic LeukemiaCompletedNCT00078234Phase 1/2
- TOCOSOL(TM) Paclitaxel in Metastatic or Locally Advanced Unresectable Transitional Cell Carcinoma of the UrotheliumCompletedNCT00077688Phase 2
- Erlotinib and Temozolomide in Treating Young Patients With Recurrent or Refractory Solid TumorsCompletedNCT00077454Phase 1
- DJ-927 and Capecitabine in Treating Patients With Locally Advanced or Metastatic Solid TumorsCompletedNCT00077077Phase 1
- Temozolomide for Treatment of Brain Metastases From Non-Small Cell Lung Cancer (Study P03247)CompletedNCT00076856Phase 2
- Gefitinib in Treating Patients With Progressive Metastatic Neuroendocrine TumorsCompletedNCT00075439Phase 2
- Surgery Versus Radiosurgery to Treat Metastatic Brain TumorsCompletedNCT00075166Phase 4
- Study Of An Oral Tyrosine Kinase Inhibitor Of VEGFR-2 To Treat Small-Volume Ovarian, Peritoneal, Fallopian Tube CancerCompletedNCT00074867Phase 2
- Irinotecan, Oxaliplatin, and Capecitabine in Treating Patients With Unresectable Solid TumorsCompletedNCT00074321Phase 1
- Study Evaluating EKB-569 in Advanced Colorectal CancerCompletedNCT00072748Phase 2
- Gemcitabine Hydrochloride and Alvocidib in Treating Patients With Solid TumorsCompletedNCT00072436Phase 1
- Soblidotin and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Solid TumorsWithdrawnNCT00072228Phase 1
- Cisplatin and Ifosfamide Combined With Either Paclitaxel or Vinblastine in Treating Men With Progressive or Recurrent Metastatic Germ Cell TumorsTerminatedNCT00072215Phase 3
- Pemetrexed Disodium in Treating Young Patients With Recurrent Solid TumorsCompletedNCT00070473Phase 1
- Ixabepilone in Treating Patients With Advanced Cisplatin-Refractory Germ Cell TumorsCompletedNCT00070096Phase 2